Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re Ron's lengthy post

I thought some of Rons post was a little in your face as well. If it makes him feel better to say I told you so good for him.

Ron and Brian keep in touch, it's possible Brian had inside information and shared it with Ron. Brian also seemed pretty sure about no more money coming from the J's settlement before he stepped down as the shareholder representative. I'm not saying it was for sure Brian but I don't know who else it could be.

Ease made the call here as well, without inside sources and I have accepted it as it seems to fit best with the facts we have. Maybe we'll be pleasantly surprised if we end up getting more some day from the J's but at this point I'm not counting on any more.

If the USPTO would have came through with the re-validation before trial. The shoe would have been on the other foot and we probably would have recieved the big payday we were all hoping for. It turns out TPL made the right call. Better to argue patents validity with the USPTO instead of Cook trying to convince a jury validity when the defense argues that the USPTO is reviewing the patents for validity. Hopfully the re-validation will happen soon so we can nail the T3 and the 20 Japanese companies that just filed the new suit against us. And for the rest of the companies out there infringinging that were unwilling to pay early.

As Billwilke and I have stated it dosn't seem fair that the patent owners are penalized during the time of the patent review process. It probably cost us $50M-$200M with the J's. IMO the life of the patents should be extended the amount of time it takes for the review. In my view the a ptent should trump prior art.

All the best,

Steve

Share
New Message
Please login to post a reply